TY - JOUR T1 - Lactoferrin as treatment for iron-deficiency anemia in children: a systematic review. AU - June,Devina, AU - Konstantin,Alvin Timothy, AU - Lumbanradja,Levina Arthauli, AU - Aryani,Astria, AU - Hengky,Antoninus, PY - 2023/9/5/medline PY - 2023/9/4/pubmed PY - 2023/9/4/entrez KW - anemia KW - children KW - iron status KW - lactoferrin KW - treatment SP - 543 EP - 554 JF - The Turkish journal of pediatrics JO - Turk J Pediatr VL - 65 IS - 4 N2 - BACKGROUND: Anemia is a common nutritional problem in children, especially those under five. Lactoferrin (Lf) as a supplement in treating iron deficiency anemia (IDA) has been studied, but its results in children have not been reviewed. This review aims to evaluate the effect of lactoferrin on children with IDA. METHODS: PubMed, ProQuest, EBSCO and Ovid databases were searched using a variation of keywords: lactoferrin, anemia, and children. The literature selected must be clinical trial-based in design. The years of the studies published were limited to 2012 and 2022. RESULTS: Eleven studies were included in the final systematic review, consisting of 10 randomized controlled trials (RCTs) and 1 non-randomized trial. Serum ferritin (SF) and hemoglobin (Hb) were found to be increased in groups treated with Lf or a combination of Lf and elemental iron compared to iron only or placebo supplementation. Adverse events such as constipation, vomiting, anorexia, and abdominal pain were found; particularly, a significant decrease in constipation is seen in Lf-treated groups. CONCLUSIONS: This study supports Lf as a superior treatment for IDA in children regarding the improvement in hematological and iron indices and fewer adverse effects. SN - 2791-6421 UR - https://www.unboundmedicine.com/medline/citation/37661669/ DB - PRIME DP - Unbound Medicine ER -